Genomics: Clinical Implementation
This channel includes news headlines and educational resources regarding the clinical implementation of genomics assays, including development, validation, quality control, standardization, and the practical and commercial considerations for labs adopting these tests.Â
Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy
Researchers looked at relapse-related markers over time in pediatric and young adult acute lymphoblastic leukemia patients after CAR T-cell treatment.
Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role
Premium
As economic and practical challenges of next-gen sequencing have eased in recent years, more groups are bringing comprehensive cancer genomic testing in house.
Postsurgical ctDNA Analysis Predicts Adjuvant Chemotherapy Benefit in NSCLC
Research out of Geneseeq and the Chinese Academy of Medical Sciences shows the value of ctDNA analysis to guide treatment and predict disease recurrence.
Lucence, Veterans' Affairs Health Care System Launch Liquid Biopsy Screening Study
The study will evaluate the feasibility of screening high-risk lung cancer patients with Lucence's LiquidHallmark assay.
BGI Genomics Program Seeks to Validate Signatera Test for Colorectal Cancer Patients in China
Premium
The molecular residual disease test from Natera was first made available to biopharmaceutical customers and clinicians across China in June.